Zusammenfassung
Die Zahl der mit dem Parkinson-Syndrom identifizierten krankheitsassoziierten Gene ist seit der Erstentdeckung im Jahre 1997 stetig – auf nunmehr insgesamt 18 Genorte – angestiegen (PARK1-18). Dies erlaubt einen tieferen Einblick in die zugrunde liegenden pathophysiologischen Grundlagen. Träger der krankheitsassoziierten Gene bieten uns die einzigartige Gelegenheit, auch die präsymptomatische Phase dieser neurodegenerativen Erkrankung zu untersuchen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Bekris LM, Mata IF, Zabetian CP (2010) The genetics of Parkinson disease. J Geriatr Psychiatry Neurol 23:228–42
Binkofski F, Reetz K, Gaser C, Hilker R, Hagenah J, Hedrich K et al. (2007) Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology 69:842–50
Braak H, Del Tredici K (2008) Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916–25
Buhmann C, Binkofski F, Klein C, Buchel C, van Eimeren T, Erdmann C et al. (2005) Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain 128(Pt 10):2281–90
Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306–18
Hilker R, Klein C, Hedrich K, Ozelius LJ, Vieregge P, Herholz K et al. (2002) The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett 323:50–4
Khan NL, Brooks DJ, Pavese N, Sweeney MG, Wood NW, Lees AJ et al. (2002a) Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. Brain 125:2248–56
Khan NL, Valente EM, Bentivoglio AR, Wood NW, Albanese A, Brooks DJ et al. (2002b) Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol 52:849–53
Klein C, Schlossmacher MG (2006) The genetics of Parkinson disease: Implications for neurological care. Nat Clin Pract Neurol 2:136–46
Pankratz N, Nichols WC, Uniacke SK, Halter C, Murrell J, Rudolph A et al. (2003) Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum Mol Genet 12:2599–608
Reetz K, Lencer R, Steinlechner S, Gaser C, Hagenah J, Buchel C et al. (2008) Limbic and Frontal Cortical Degeneration Is Associated with Psychiatric Symptoms in PINK1 Mutation Carriers. Biol Psychiatry 64(3):241–7
Reetz K, Tadic V, Kasten M, Bruggemann N, Schmidt A, Hagenah J et al. (2010) Structural imaging in the presymptomatic stage of genetically determined parkinsonism. Neurobiol Dis 39:402–8
Steinlechner S, Stahlberg J, Volkel B, Djarmati A, Hagenah J, Hiller A et al. (2007) Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations. J Neurol Neurosurg Psychiatry 78:532–5
Vegt JP van der, van Nuenen BF, Bloem BR, Klein C, Siebner HR (2009) Imaging the impact of genes on Parkinson's disease. Neuroscience 164(1):191–204
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Reetz, K. (2012). Bildgebung genetischer Aspekte des Parkinson-Syndroms. In: Schneider, F. (eds) Positionen der Psychiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25476-5_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-25476-5_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25475-8
Online ISBN: 978-3-642-25476-5
eBook Packages: Medicine (German Language)